Hanson & Doremus Investment Management Gossamer Bio, Inc. Put Options Transaction History
Hanson & Doremus Investment Management
- $637 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$22.2 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$21.9 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$12.1 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$10.7 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.75 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $114M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...